Your Innovative Source of Life Science Products and Services

Galiximab (CD80 (B7-1 – CD28LG2)) – Research Grade Biosimilar

ZY10-175 Category:
Galiximab (CD80 (B7-1 – CD28LG2)) – Research Grade Biosimilar
0.1 mg

$644.00

9999 in stock


Product Description

Size

0.1 mg

Host
Species Reactivity
Applications
Clonality

Recombinant Monoclonal

Class

Cancer

Conjugation

Unconjugated

Dataseet – Request by Email at zinfo@zyagen.com

X